Crossmark

CD14/TLR4 priming potentially recalibrates and exerts anti-tumor efficacy in tumor associated macrophages in a mouse model of pancreatic carcinoma

Published Online: 2016-08-11

Authors

Prakash, Hridayesh

Nadella, Vinod

Singh, Sandhya

Schmitz-Winnenthal, Hubertus
License Information

Text and Data Mining valid from 2016-08-11

Version of Record valid from 2016-08-11
More Information

Article History

Received: 24 March 2016

Accepted: 20 July 2016

First Online: 11 August 2016

Competing interests

: The authors declare no competing financial interests.

Document is current